E-viri
Recenzirano
-
Mazurek, Agnieszka M; Rutkowski, Tomasz; Fiszer-Kierzkowska, Anna; Małusecka, Ewa; Składowski, Krzysztof
Oral oncology, 03/2016, Letnik: 54Journal Article
Highlights • A higher level of cfDNA was found in patients with OPSCC than non-OPSCC patients. • A level of cfDNA in N2–N3 positive disease is significantly higher than in N0–N1. • A level of cfDNA in stage IV is significantly higher than in I–III stages. • 14% of HNSCC patients were HPV16/18-positive in plasma (96.4% cases possess HPV16).
